Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA Growth
16.03%
Quarterly · Period ending:
BIO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported16.03%period ending
Latest reported16.03%period ending
BIO Quarterly EBITDA YoY % (22.44% → 16.03%)
Year-over-year change
High-resolution chart · PNG
BIO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 16.0317% | |
| -576.8539% | |
| 216.0963% | |
| -141.0433% | |
| 117.0659% | |
| -75.2986% | |
| -277.2978% | |
| 388.5942% | |
| -88.5042% | |
| 307.0733% | |
| -58.1831% | |
| 215.7696% | |
| -23.5582% | |
| 103.0658% | |
| 157.0344% | |
| -103.1911% | |
| -198.7023% | |
| -425.5341% | |
| -279.0179% | |
| 193.3278% | |
| -7.4276% | |
| 41.8248% | |
| 57.9353% | |
| 682.3789% | |
| 59.0797% | |
| -19.5655% | |
| 170.8363% | |
| -175.6826% | |
| 112.5416% | |
| 29.0318% | |
| -1,265.6935% | |
| 390.389% | |
| 761.4582% | |
| 1,434.7286% | |
| 789.513% | |
| 19.3714% | |
| -36.9738% | |
| -1.632% | |
| -89.7408% | |
| 3.105% | |
| -8.4% | |
| -11.684% | |
| 3.9164% | |
| -8.7031% | |
| -15.6532% | |
| 17.269% | |
| -3.24% | |
| 6.4173% | |
| -5.1574% | |
| -15.3863% | |
| -12.1351% | |
| -32.6585% | |
| -13.1222% | |
| -24.4907% | |
| -10.3571% | |
| 0.5503% | |
| 10.6395% | |
| -2.8677% | |
| 11.3268% | |
| -0.144% | |
| 3.8887% | |
| 1.4497% | |
| 88.9702% | |
| 7.2815% | |
| 12.5589% | |
| 25.1189% | |
| 52.2012% | |
| 21.3619% | |
| 4.9684% | |
| -3.2947% | |
| -32.166% | |
| 45.4397% | |
| 61.6159% | |
| 42.5627% | |
| 21.873% | |
| 19.1605% | |
| -11.5347% | |
| -11.7886% | |
| 17.1213% | |
| 9.5861% | |
| 32.3234% | |
| 9.1972% | |
| -15.0463% | |
| -0.0201% | |
| -7.4647% | |
| 17.3637% | |
| 1.3348% | |
| -10.1596% | |
| -0.9075% | |
| -12.913% | |
| 1.1985% | |
| -2.8567% | |
| 12.5696% | |
| 22.1492% | |
| -2.4058% | |
| 47.4742% | |
| 13.2655% | |
| -13.0933% | |
| 74.7479% | |
| 19.5066% |